Cargando…
A phase IV, multicentre, open‐label study of emicizumab prophylaxis in people with haemophilia A with or without FVIII inhibitors undergoing minor surgical procedures
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544354/ https://www.ncbi.nlm.nih.gov/pubmed/35510949 http://dx.doi.org/10.1111/hae.14574 |
| _version_ | 1784804578736209920 |
|---|---|
| author | Escobar, Miguel Dunn, Amy Quon, Doris Trzaskoma, Ben Lee, Lucy Ko, Richard H. Carpenter, Shannon L. |
| author_facet | Escobar, Miguel Dunn, Amy Quon, Doris Trzaskoma, Ben Lee, Lucy Ko, Richard H. Carpenter, Shannon L. |
| author_sort | Escobar, Miguel |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9544354 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95443542022-10-14 A phase IV, multicentre, open‐label study of emicizumab prophylaxis in people with haemophilia A with or without FVIII inhibitors undergoing minor surgical procedures Escobar, Miguel Dunn, Amy Quon, Doris Trzaskoma, Ben Lee, Lucy Ko, Richard H. Carpenter, Shannon L. Haemophilia Letters to the Editor John Wiley and Sons Inc. 2022-05-05 2022-07 /pmc/articles/PMC9544354/ /pubmed/35510949 http://dx.doi.org/10.1111/hae.14574 Text en © 2022 The Authors. Haemophilia published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letters to the Editor Escobar, Miguel Dunn, Amy Quon, Doris Trzaskoma, Ben Lee, Lucy Ko, Richard H. Carpenter, Shannon L. A phase IV, multicentre, open‐label study of emicizumab prophylaxis in people with haemophilia A with or without FVIII inhibitors undergoing minor surgical procedures |
| title | A phase IV, multicentre, open‐label study of emicizumab prophylaxis in people with haemophilia A with or without FVIII inhibitors undergoing minor surgical procedures |
| title_full | A phase IV, multicentre, open‐label study of emicizumab prophylaxis in people with haemophilia A with or without FVIII inhibitors undergoing minor surgical procedures |
| title_fullStr | A phase IV, multicentre, open‐label study of emicizumab prophylaxis in people with haemophilia A with or without FVIII inhibitors undergoing minor surgical procedures |
| title_full_unstemmed | A phase IV, multicentre, open‐label study of emicizumab prophylaxis in people with haemophilia A with or without FVIII inhibitors undergoing minor surgical procedures |
| title_short | A phase IV, multicentre, open‐label study of emicizumab prophylaxis in people with haemophilia A with or without FVIII inhibitors undergoing minor surgical procedures |
| title_sort | phase iv, multicentre, open‐label study of emicizumab prophylaxis in people with haemophilia a with or without fviii inhibitors undergoing minor surgical procedures |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544354/ https://www.ncbi.nlm.nih.gov/pubmed/35510949 http://dx.doi.org/10.1111/hae.14574 |
| work_keys_str_mv | AT escobarmiguel aphaseivmulticentreopenlabelstudyofemicizumabprophylaxisinpeoplewithhaemophiliaawithorwithoutfviiiinhibitorsundergoingminorsurgicalprocedures AT dunnamy aphaseivmulticentreopenlabelstudyofemicizumabprophylaxisinpeoplewithhaemophiliaawithorwithoutfviiiinhibitorsundergoingminorsurgicalprocedures AT quondoris aphaseivmulticentreopenlabelstudyofemicizumabprophylaxisinpeoplewithhaemophiliaawithorwithoutfviiiinhibitorsundergoingminorsurgicalprocedures AT trzaskomaben aphaseivmulticentreopenlabelstudyofemicizumabprophylaxisinpeoplewithhaemophiliaawithorwithoutfviiiinhibitorsundergoingminorsurgicalprocedures AT leelucy aphaseivmulticentreopenlabelstudyofemicizumabprophylaxisinpeoplewithhaemophiliaawithorwithoutfviiiinhibitorsundergoingminorsurgicalprocedures AT korichardh aphaseivmulticentreopenlabelstudyofemicizumabprophylaxisinpeoplewithhaemophiliaawithorwithoutfviiiinhibitorsundergoingminorsurgicalprocedures AT carpentershannonl aphaseivmulticentreopenlabelstudyofemicizumabprophylaxisinpeoplewithhaemophiliaawithorwithoutfviiiinhibitorsundergoingminorsurgicalprocedures AT escobarmiguel phaseivmulticentreopenlabelstudyofemicizumabprophylaxisinpeoplewithhaemophiliaawithorwithoutfviiiinhibitorsundergoingminorsurgicalprocedures AT dunnamy phaseivmulticentreopenlabelstudyofemicizumabprophylaxisinpeoplewithhaemophiliaawithorwithoutfviiiinhibitorsundergoingminorsurgicalprocedures AT quondoris phaseivmulticentreopenlabelstudyofemicizumabprophylaxisinpeoplewithhaemophiliaawithorwithoutfviiiinhibitorsundergoingminorsurgicalprocedures AT trzaskomaben phaseivmulticentreopenlabelstudyofemicizumabprophylaxisinpeoplewithhaemophiliaawithorwithoutfviiiinhibitorsundergoingminorsurgicalprocedures AT leelucy phaseivmulticentreopenlabelstudyofemicizumabprophylaxisinpeoplewithhaemophiliaawithorwithoutfviiiinhibitorsundergoingminorsurgicalprocedures AT korichardh phaseivmulticentreopenlabelstudyofemicizumabprophylaxisinpeoplewithhaemophiliaawithorwithoutfviiiinhibitorsundergoingminorsurgicalprocedures AT carpentershannonl phaseivmulticentreopenlabelstudyofemicizumabprophylaxisinpeoplewithhaemophiliaawithorwithoutfviiiinhibitorsundergoingminorsurgicalprocedures |